Dermatological Drugs Market Report 2022-2032

VisionGain
442 Pages - VISION10221
$4,740.00

The Dermatology Drugs Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.


Factors Such As the Impact of Skin Disease on Quality Of Life and the Resulting Need to Tackle This Are Driving the Market Growth

WHO (World Health Organization) defined it as disability in skin conditions that impact the well-being, mental health, ability to function, and social participation and restrict engagement with others. Quality of life (QoL) tools help in these and some of the tools include the Dermatology Life Quality Index (DLQI) and the Skindex. The QoL can be impaired for a variety of reasons mainly due to symptoms of the disease. Atopic eczema is one disease where the psychological burden is particularly pronounced. Psychosomatic involvement is the main characteristic of atopic eczema and is considered in therapeutic management. Furthermore, QOL in atopic dermatitis has also been included in educational programs, under the name ‘eczema school’. In the UK, there is a charity called Eczema Outreach Scotland that supported families living in Scotland that gradually expanded to support families in England, Wales, and Northern Ireland and was named Eczema Outreach Support with a focus on practical and emotional aspects of having a child with eczema.


The rise in demand for dermatological products post COVID-19

There has been a sudden surge in demand for dermatological drugs as consumers and patients are becoming more aware and conscious. Moreover, as consumers presume their work post-COVID-19, exposure to heat, pollution, and stress has boosted the demand for anti-acne, skin brightening, anti-fungal, and emollients. With a long hiatus of 2 years due to COVID-19, there has been a rise in footfall observed for dermatology consulting thereby boosting the overall growth of the dermatology drugs market.


What Questions Should You Ask before Buying a Market Research Report?

• How is the Dermatology Drugs Market evolving?

• What is driving and restraining the Dermatology Drugs Market?

• How will each dermatology drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?

• How will the market shares for each Dermatology Drugs submarket develop from 2022 to 2032?

• What will be the main driver for the overall market from 2022 to 2032?

• Will leading Dermatology Drugs Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?

• Who are the leading players and what are their prospects over the forecast period?

• What are the Dermatology Drugs projects for these leading companies?

• How will the industry evolve during the period between 2022 and 2032? What are the implications of Dermatology Drugs projects taking place now and over the next 10 years?

• Is there a greater need for product commercialization to further scale the Dermatology Drugs Market?

• Where is the Dermatology Drugs Market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?


You need to discover how this will impact the Dermatology Drugs Market today, and over the next 10 years:

• Our 442-page report provides 195 tables and 270 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.


This report tells you TODAY how the Dermatology Drugs Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.


Forecasts to 2032 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Dermatology Drugs prices and recent developments.


This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.


Segments Covered in the Report


Disease

• Psoriasis

• Dermatitis

• Acne

• Skin Infection

• Antiaging

• Antifungal

• Skin Cancer

• Hair Loss

• Hyperpigmentation

• Other Diseases


Type

• Generics

• Biologics


Route of Administration

• Topical

• Oral

• Parenteral


In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and xx leading national markets:


North America

• U.S.

• Canada


Europe

• Germany

• UK

• France

• Spain

• Italy

• Russia

• Rest of Europe


Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific


Latin America

• Brazil

• Mexico

• Rest of Latin America


MEA

• GCC

• South Africa

• Rest of MEA


The report also includes profiles and for some of the leading companies in the Dermatology Drugs Market, 2022 to 2032, with a focus on this segment of these companies’ operations.


Leading companies and the potential for market growth

• Abbott Laboratories

• AbbVie

• Bayer Pharmaceuticals

• BMS

• Cipla Pharmaceutical

• Dr. Reddy’s Laboratories

• Eli Lilly and Company

• Glenmark Pharmaceuticals Limited

• GSK

• Janssen Pharma

• Lupin Limited

• Merck

• Pfizer

• Roche

• Sanofi Pasteur Pharmaceutical

• Sun Pharmaceutical Industries Limited

• Taro Pharmaceutical Industries Ltd.

• Zydus Cadila Healthcare Pharmaceutical


Overall world revenue for the Dermatology Drugs Market, 2022 to 2032 in terms of value the market will surpass US$26.1 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.


How will the Dermatology Drugs Market, 2022 to 2032 report help you?

In summary, our 440+ page report provides you with the following knowledge:


• Revenue forecasts to 2032 for Dermatology Drugs Market, 2022 to 2032 Market, with forecasts for disease, route of administration, type, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.


• Revenue forecasts to 2032 for five regional and 21 key national markets – See forecasts for the Dermatology Drugs Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Russia, China, India, Japan, and Australia among other prominent economies.


• Prospects for established firms and those seeking to enter the market – including company profiles for 18 of the major companies involved in the Dermatology Drugs Market, 2022 to 2032.


Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.


Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Dermatology Drugs Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

'

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Dermatology Drugs Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary
2.1 Geographical Snapshot: Global Dermatology Drugs Market
2.2 Disease Segment: Market Attractiveness Index
2.3 Route of Administration Segment: Market Attractiveness Index

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.2 Market Restraining Factors
3.2.3 Market Opportunities
3.2.4 Challenges
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants

4 Global Dermatology Drugs Market Analysis by Disease
4.1 Key Findings
4.2 Disease Segment Growth Prospects
4.3 Global Dermatology Drugs Market Size Estimation and Forecast by Disease
4.4 Psoriasis
4.4.1 Subtypes
4.4.2 Treatments Available
4.4.3 Psoriasis Treatment Benefits and Risks
4.4.4 Major Engineered Protein Treatments In Use
4.4.5 Cost of Treatment
4.4.6 Psoriasis Treatment Pipeline
4.4.7 Psoriasis Market Forecast by Region, 2022-2032 (US$ Bn)
4.4.8 Psoriasis Market Share by Region, 2022-2032 (%)
4.5 Dermatitis
4.5.1 Irritant Contact Dermatitis
4.5.2 Allergic response after re-exposure.
4.5.3 Dermatitis Pipeline
4.5.4 Dermatitis Market Forecast by Region, 2022-2032 (US$ Bn)
4.5.5 Dermatitis Market Share by Region, 2022-2032 (%)
4.6 Acne
4.6.1 Comedonal
4.6.2 Papulopustular
4.6.3 Nodulocystic
4.6.4 Treatments Available
4.6.5 Retinoids
4.6.6 Antibiotics
4.6.7 Anti-inflammatory Drugs
4.6.8 Hormonal Therapy
4.6.9 Treatment Failure
4.6.10 Acne Treatment Pipeline
4.6.11 Acne Market Forecast by Region, 2022-2032 (US$ Bn)
4.6.12 Acne Market Share by Region, 2022-2032 (%)
4.7 Skin Infections
4.7.1 Bacterial Infections
4.7.2 Fungal Infections
4.7.3 Viral Infections
4.7.4 Skin Infection Treatment Pipeline
4.7.5 Skin Infections Market Forecast by Region, 2022-2032 (US$ Bn)
4.7.6 Skin Infections Market Share by Region, 2022-2032 (%)
4.8 Antiaging
4.8.1 Antiaging Market Forecast by Region, 2022-2032 (US$ Bn)
4.8.2 Antiaging Market Share by Region, 2022-2032 (%)
4.9 Antifungal
4.9.1 Antifungal Market Forecast by Region, 2022-2032 (US$ Bn)
4.9.2 Antifungal Market Share by Region, 2022-2032 (%)
4.10 Skin Cancer
4.10.1 Skin Cancer Market Forecast by Region, 2022-2032 (US$ Bn)
4.10.2 Skin Cancer Market Share by Region, 2022-2032 (%)
4.11 Hair Loss
4.11.1 Hair Loss Market Forecast by Region, 2022-2032 (US$ Bn)
4.11.2 Hair Loss Market Share by Region, 2022-2032 (%)
4.12 Hyperpigmentation
4.12.1 Hyperpigmentation Market Forecast by Region, 2022-2032 (US$ Bn)
4.12.2 Hyperpigmentation Market Share by Region, 2022-2032 (%)
4.13 Other diseases
4.13.1 Other Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
4.13.2 Other Disease Market Share by Region, 2022-2032 (%)

5 Global Dermatology Drugs Market Analysis by Route of Administration
5.1 Key Findings
5.2 Route of Administration Segment Growth Prospects
5.3 Global Dermatology Drugs Market Size Estimation and Forecast by Route of Administration
5.4 Global Dermatology Drugs Market Share by Route of Administration, 2022 & 2032
5.5 Topical
5.5.1 Topical Market Forecast by Region, 2022-2032 (US$ Bn)
5.5.2 Topical Market Share by Region, 2022-2032 (%)
5.6 Oral
5.6.1 Oral Market Forecast by Region, 2022-2032 (US$ Bn)
5.6.2 Oral Market Share by Region, 2022-2032 (%)
5.7 Parenteral
5.7.1 Parenteral Market Forecast by Region, 2022-2032 (US$ Bn)
5.7.2 Parenteral Market Share by Region, 2022-2032 (%)

6 Global Dermatology Drugs Market Analysis by Generics/Biologics
6.1 Key Findings
6.2 Segment Growth Prospects, By Type
6.3 Global Dermatology Drugs Market Share by Generics/Biologics, 2022 & 2032
6.3.1 Dermatology Drugs Market, By Generics
6.3.1.1 Generic Drugs Market Size Estimation and Forecast
6.3.2 Dermatology Drugs Market, By Branded/ Biologics
6.3.2.1 Biologic Drugs Market Size Estimation and Forecast

7 Global Dermatology Drugs Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
7.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

8 North America Dermatology Drugs Market Analysis
8.1 Key Findings
8.2 North America Dermatology Drugs Market Attractiveness Index
8.3 North America Dermatology Drugs Market by Country, 2022, 2027 & 2032 (US$ bn)
8.4 North America Dermatology Drugs Market Size Estimation and Forecast by Country
8.5 North America Dermatology Drugs Market Size Estimation and Forecast by Disease
8.6 North America Dermatology Drugs Market Size Estimation and Forecast by Route of Administration
8.7 U.S.
8.7.1 U.S. Dermatology Drugs Market by Disease
8.7.2 U.S. Dermatology Drugs Market by Route of Administration
8.8 Canada
8.8.1 Canada Dermatology Drugs Market by Disease
8.8.2 Canada Dermatology Drugs Market by Route of Administration

9 Europe Dermatology Drugs Market Analysis
9.1 Key Findings
9.2 Europe Dermatology Drugs Market Attractiveness Index
9.3 Europe Dermatology Drugs Market by Country, 2022, 2027 & 2032 (US$ bn)
9.4 Europe Dermatology Drugs Market Size Estimation and Forecast by Country
9.5 Europe Dermatology Drugs Market Size Estimation and Forecast by Disease
9.6 Europe Dermatology Drugs Market Size Estimation and Forecast by Route of Administration
9.7 Germany
9.7.1 Germany Dermatology Drugs Market by Disease
9.7.2 Germany Dermatology Drugs Market by Route of Administration
9.8 U.K.
9.8.1 U.K. Dermatology Drugs Market by Disease
9.8.2 U.K. Dermatology Drugs Market by Route of Administration
9.9 France
9.9.1 France Dermatology Drugs Market by Disease
9.9.2 France Dermatology Drugs Market by Route of Administration
9.10 Italy
9.10.1 Italy Dermatology Drugs Market by Disease
9.10.2 Italy Dermatology Drugs Market by Route of Administration
9.11 Spain
9.11.1 Spain Dermatology Drugs Market by Disease
9.11.2 Spain Dermatology Drugs Market by Route of Administration
9.12 Russia
9.12.1 Russia Dermatology Drugs Market by Disease
9.12.2 Russia Dermatology Drugs Market by Route of Administration
9.13 Rest of Europe
9.13.1 Rest of Europe Dermatology Drugs Market by Disease
9.13.2 Rest of Europe Dermatology Drugs Market by Route of Administration

10 Asia Pacific Dermatology Drugs Market Analysis
10.1 Key Findings
10.2 Asia Pacific Dermatology Drugs Market Attractiveness Index
10.3 Asia Pacific Dermatology Drugs Market by Country, 2022, 2027 & 2032 (US$ bn)
10.4 Asia Pacific Dermatology Drugs Market Size Estimation and Forecast by Country
10.5 Asia Pacific Dermatology Drugs Market Size Estimation and Forecast by Disease
10.6 Asia Pacific Dermatology Drugs Market Size Estimation and Forecast by Route of Administration
10.7 Japan
10.7.1 Japan Dermatology Drugs Market by Disease
10.7.2 Japan Dermatology Drugs Market by Route of Administration
10.8 China
10.8.1 China Dermatology Drugs Market by Disease
10.8.2 China Dermatology Drugs Market by Route of Administration
10.9 India
10.9.1 India Dermatology Drugs Market by Disease
10.9.2 India Dermatology Drugs Market by Route of Administration
10.10 South Korea
10.10.1 South Korea Dermatology Drugs Market by Disease
10.10.2 South Korea Dermatology Drugs Market by Route of Administration
10.11 Australia
10.11.1 Australia Dermatology Drugs Market by Disease
10.11.2 Australia Dermatology Drugs Market by Route of Administration
10.12 Rest of APAC
10.12.1 Rest of APAC Dermatology Drugs Market by Disease
10.12.2 Rest of APAC Dermatology Drugs Market by Route of Administration

11 Latin America Dermatology Drugs Market Analysis
11.1 Key Findings
11.2 Latin America Dermatology Drugs Market Attractiveness Index
11.3 Latin America Dermatology Drugs Market by Country, 2022, 2027 & 2032 (US$ bn)
11.4 Latin America Dermatology Drugs Market Size Estimation and Forecast by Country
11.5 Latin America Dermatology Drugs Market Size Estimation and Forecast by Disease
11.6 Latin America Dermatology Drugs Market Size Estimation and Forecast by Route of Administration
11.7 Brazil
11.7.1 Brazil Dermatology Drugs Market by Disease
11.7.2 Brazil Dermatology Drugs Market by Route of Administration
11.8 Mexico
11.8.1 Mexico Dermatology Drugs Market by Disease
11.8.2 Mexico Dermatology Drugs Market by Route of Administration
11.9 Rest of Latin America
11.9.1 Rest of LATAM Dermatology Drugs Market by Disease
11.9.2 Rest of LATAM Dermatology Drugs Market by Route of Administration

12 MEA Dermatology Drugs Market Analysis
12.1 Key Findings
12.2 MEA Dermatology Drugs Market Attractiveness Index
12.3 MEA Dermatology Drugs Market by Country, 2022, 2027 & 2032 (US$ bn)
12.4 MEA Dermatology Drugs Market Size Estimation and Forecast by Country
12.5 MEA Dermatology Drugs Market Size Estimation and Forecast by Disease
12.6 MEA Dermatology Drugs Market Size Estimation and Forecast by Route of Administration
12.7 South Africa
12.7.1 South Africa Dermatology Drugs Market by Disease
12.7.2 South Africa Dermatology Drugs Market by Route of Administration
12.8 GCC
12.8.1 GCC Dermatology Drugs Market by Disease
12.8.2 GCC Dermatology Drugs Market by Route of Administration
12.9 Rest of MEA
12.9.1 Rest of MEA Dermatology Drugs Market by Disease
12.9.2 Rest of MEA Dermatology Drugs Market by Route of Administration

13 Competitive Landscape
13.1 Company Share Analysis
13.2 Key Business Strategy Analysis

14 Company Profiles
14.1 Pfizer
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.4 Product Benchmarking
14.1.5 Strategic Outlook
14.2 Merck
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 GSK
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 AbbVie
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Janssen Pharma
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 BMS
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Roche
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Abbott Laboratories
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Bayer Pharmaceuticals
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Zydus Cadila Healthcare Pharmaceutical
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Cipla Pharmaceutical
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Dr. Reddy’s Laboratories
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Eli Lilly and Company
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Glenmark Pharmaceuticals Limited
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Lupin Limited
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
14.16 Sanofi Pasteur Pharmaceutical
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
14.17 Sun Pharmaceutical Industries Limited
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.17.5 Strategic Outlook
14.18 Taro Pharmaceutical Industries Ltd.
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from
15.2 Recommendations for Market Players

List of Tables
Table 1 Global Dermatology Drugs Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (V-shaped Recovery)
Table 3 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (U-shaped Recovery)
Table 4 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (W-shaped Recovery)
Table 5 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (L-shaped Recovery)
Table 6 Dermatological Drugs Diseases Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 7 Cost of Psoriasis Therapies in A Typical Western European Country ($)
Table 8 Psoriasis Drug Pipeline
Table 9 Psoriasis Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 10 Global Products Undergoing Research as Potential Treatments for Dermatitis
Table 11 Dermatitis Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 12 Global Potential Products for Acne Treatment
Table 13 Acne Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 14 Global Antifungals for Superficial Fungal Infections
Table 15 Global Antiviral Drugs Available
Table 16 Global Potential Drug Candidates for Skin Infection Treatments
Table 17 Skin Infection Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 18 Antiaging Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 19 Antifungal Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 20 Skin cancer Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 21 Hair Loss Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 22 Hyperpigmentation Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 23 Other Diseases Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 24 Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 25 Topical Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 26 Oral Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 27 Parenteral Market, by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 28 Dermatological Drugs Generics Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 29 Dermatological Drugs Biologics Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 30 Dermatological Drugs Market, By Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 31 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (V-shaped Recovery)
Table 32 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (U-shaped Recovery)
Table 33 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (W-shaped Recovery)
Table 34 Dermatology Drugs Market, By Region, 2022-2032 (US$ Bn, AGR %, CAGR %) (L-shaped Recovery)
Table 35 North America Dermatological Drugs Market, By Country, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 36 North America Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 37 North America Dermatological Drugs Market by Psoriasis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 38 North America Dermatological Drugs Market by Dermatitis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 39 North America Dermatological Drugs Market by Acne Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 40 North America Dermatological Drugs Market by Skin Infections Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 41 North America Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 42 US Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 43 US Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 44 US Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 45 Canada Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 46 Canada Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 47 Canada Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 48 Europe Dermatological Drugs Market, By Country, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 49 Europe Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 50 Europe Dermatological Drugs Market by Psoriasis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 51 Europe Dermatological Drugs Market by Dermatitis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 52 Europe Dermatological Drugs Market by Acne Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 53 Europe Dermatological Drugs Market by Skin Infections Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 54 Europe Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 55 Germany Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 56 Germany Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 57 Germany Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 58 UK Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 59 UK Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 60 UK Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 61 France Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 62 France Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 63 France Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 64 Italy Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 65 Italy Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 66 Italy Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 67 Spain Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 68 Spain Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 69 Spain Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 70 Russia Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 71 Russia Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 72 Russia Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 73 Rest of Europe Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 74 Rest of Europe Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 75 Rest of Europe Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 76 Asia Pacific Dermatological Drugs Market, By Country, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 77 Asia Pacific Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 78 Asia-Pacific Dermatological Drugs Market by Psoriasis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 79 Asia-Pacific Dermatological Drugs Market by Dermatitis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 80 Asia-Pacific Dermatological Drugs Market by Acne Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 81 Asia-Pacific Dermatological Drugs Market by Skin Infections Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 82 Asia Pacific Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 83 Japan Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 84 Japan Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 85 Japan Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 86 China Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 87 China Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 88 China Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 89 India Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 90 India Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 91 India Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 92 South Korea Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 93 South Korea Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 94 South Korea Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 95 Australia Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 96 Australia Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 97 Australia Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 98 Rest of Asia Pacific Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 99 Rest of Asia Pacific Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 100 Rest of Asia Pacific Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 101 Latin America Dermatological Drugs Market, By Country, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 102 Latin America Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 103 LATAM Dermatological Drugs Market by Psoriasis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 104 LATAM Dermatological Drugs Market by Dermatitis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 105 LATAM Dermatological Drugs Market by Acne Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 106 LATAM Dermatological Drugs Market by Skin Infections Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 107 Latin America Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 108 Brazil Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 109 Brazil Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 110 Brazil Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 111 Mexico Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 112 Mexico Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 113 Mexico Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 114 Rest of Latin America Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 115 Rest of LATAM Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 116 Rest of LATAM Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 117 MEA Dermatological Drugs Market, By Country, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 118 MEA Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 119 MEA Dermatological Drugs Market by Psoriasis Drugs, 2022-2032 (USD Bn, AGR (%), CAGR(%))
Table 120 MEA Dermatological Drugs Market by Dermatitis Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 121 MEA Dermatological Drugs Market by Acne Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 122 MEA Dermatological Drugs Market by Skin Infections Drugs, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 123 MEA Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 124 South Africa Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 125 South Africa Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 126 South Africa Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 127 GCC Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 128 GCC Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 129 GCC Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 130 Rest of MEA Dermatological Drugs Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 131 Rest of MEA Dermatological Drugs Disease Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 132 Rest of MEA Dermatological Drugs Route of Administration Market, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Table 133 Key Business Strategies Adopted by Key Players in Global Dermatology Drugs Market
Table 134 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 Pfizer: Product Benchmarking
Table 136 Pfizer Inc: Company Product Pipeline
Table 137 Pfizer Inc: Company Recent Developments
Table 138 Merck: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Merck: Product Benchmarking
Table 140 Merck: Company Recent Developments
Table 141 GSK: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 GSK: Product Benchmarking
Table 143 GlaxoSmithKline: Company Product Pipeline
Table 144 GlaxoSmithKline: Company Recent Developments
Table 145 AbbVie: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website)
Table 146 AbbVie: Product Benchmarking
Table 147 AbbVie Inc: Company Product Pipeline
Table 148 AbbVie Inc: Company Recent Developments
Table 149 Janssen Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Janssen Pharma: Product Benchmarking
Table 151 Janssen Pharma: Company Product Pipeline
Table 152 Janssen Pharma: Company Recent Developments
Table 153 BMS: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website)
Table 154 BMS: Product Benchmarking
Table 155 Bristol-Myers Squibb: Company Product Pipeline
Table 156 Bristol-Myers Squibb: Company Recent Developments
Table 157 Roche: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Roche: Product Benchmarking
Table 159 F. Hoffmann-La Roche Ltd: Company Recent Developments
Table 160 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 161 Bayer Pharmaceuticals: Product Benchmarking
Table 162 Bayer Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Bayer Pharmaceuticals: Product Benchmarking
Table 164 Bayer Pharmaceuticals: Company Recent Developments
Table 165 Zydus Cadila Healthcare Pharmaceutical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Zydus Cadila Healthcare Pharmaceutical: Product Benchmarking
Table 167 Zydus Cadila Healthcare Pharmaceuticals: Company Recent Developments
Table 168 Cipla Pharmaceutical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Cipla Pharmaceutical: Product Benchmarking
Table 170 Cipla Pharmaceutical: Company Recent Developments
Table 171 Dr. Reddy’s Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 172 Dr. Reddy’s Laboratories: Product Benchmarking
Table 173 Dr. Reddy’s Laboratories: Company Recent Developments
Table 174 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 175 Eli Lilly and Company: Product Benchmarking
Table 176 Eli Lilly and Company: Company Product Pipeline
Table 177 Eli Lilly and Company: Company Recent Developments
Table 178 Glenmark Pharmaceuticals Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 179 Glenmark Pharmaceuticals Limited: Product Benchmarking
Table 180 Glenmark Pharmaceuticals Limited: Company Product Pipeline
Table 181 Glenmark Pharmaceuticals Limited: Company Recent Developments
Table 182 Lupin Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 183 Lupin Limited: Product Benchmarking
Table 184 Lupin Limited: Company Recent Developments
Table 185 Sanofi Pasteur Pharmaceutical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 186 Sanofi Pasteur Pharmaceutical: Product Benchmarking
Table 187 Sanofi Pasteur Pharmaceutical: Company Product Pipeline
Table 188 Sanofi Pasteur Pharmaceutical: Company Recent Developments
Table 189 Sun Pharmaceutical Industries Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 190 Sun Pharmaceutical Industries Limited: Product Benchmarking
Table 191 Sun Pharmaceutical Industries Limited: Company Product Pipeline
Table 192 Sun Pharmaceutical Industries Limited: Company Recent Developments
Table 193 Taro Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 194 Taro Pharmaceutical Industries Ltd.: Product Benchmarking
Table 195 Taro Pharmaceutical Industries Ltd: Company Recent Developments

List of Figures
Figure 1 Global Dermatology Drugs Market Segmentation
Figure 2 Global Dermatology Drugs Market Forecast by Region: Market Attractiveness Index
Figure 3 Global Dermatology Drugs Market by Disease: Market Attractiveness Index
Figure 4 Global Dermatology Drugs Market by Route of Administration: Market Attractiveness Index
Figure 5 Global Dermatology Drugs Market: Market Dynamics
Figure 6 Global COVID Impact Analysis: Dermatology Drugs Market Recovery Scenarios
Figure 7 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Global Dermatology Drugs Market: Porter’s Five Forces Analysis
Figure 12 Global Dermatology Drugs Market Forecast by Disease 2022, 2027, 2032 (Revenue, CAGR %)
Figure 13 Global Dermatology Drugs Market Share Forecast by Disease, 2022, 2027, 2032 (%)
Figure 14 Global Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 15 Psoriasis Market Forecast by Region, 2022-2032 (US$ billion)
Figure 16 Psoriasis Market Share Forecast by Region, 2022-2032 (%)
Figure 17 Dermatitis Market Forecast by Region, 2022-2032 (US$ billion)
Figure 18 Dermatitis Market Share Forecast by Region, 2022-2032 (%)
Figure 19 Acne Market Forecast by Region, 2022-2032 (US$ billion)
Figure 20 Acne Market Share Forecast by Region, 2022-2032 (%)
Figure 21 Skin Infections Market Forecast by Region, 2022-2032 (US$ billion)
Figure 22 Skin Infections Market Share Forecast by Region, 2022-2032 (%)
Figure 23 Antiaging Market Forecast by Region, 2022-2032 (US$ billion)
Figure 24 Antiaging Market Share Forecast by Region, 2022-2032 (%)
Figure 25 Antifungal Market Forecast by Region, 2022-2032 (US$ billion)
Figure 26 Antifungal Market Share Forecast by Region, 2022-2032 (%)
Figure 27 Skin Cancer Market Forecast by Region, 2022-2032 (US$ billion)
Figure 28 Skin Cancer Market Share Forecast by Region, 2022-2032 (%)
Figure 29 Hair Loss Market Forecast by Region, 2022-2032 (US$ billion)
Figure 30 Hair Loss Market Share Forecast by Region, 2022-2032 (%)
Figure 31 Hyperpigmentation Market Forecast by Region, 2022-2032 (US$ billion)
Figure 32 Hyperpigmentation Market Share Forecast by Region, 2022-2032 (%)
Figure 33 Other Disease Market Forecast by Region, 2022-2032 (US$ billion)
Figure 34 Other Disease Market Share Forecast by Region, 2022-2032 (%)
Figure 35 Global Dermatology Drugs Market Forecast by Route of Administration 2022, 2027, 2032 (Revenue, CAGR%)
Figure 36 Global Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 37 Global Dermatology Drugs Market Share Forecast by Route of Administration, 2022, 2032 (%)
Figure 38 Topical Market Forecast by Region, 2022-2032 (US$ billion)
Figure 39 Topical Market Share Forecast by Region, 2022-2032 (%)
Figure 40 Oral Market Forecast by Region, 2022-2032 (US$ billion)
Figure 41 Oral Market Share Forecast by Region, 2022-2032 (%)
Figure 42 Parenteral Market Forecast by Region, 2022-2032 (US$ billion)
Figure 43 Parenteral Market Share Forecast by Region, 2022-2032 (%)
Figure 44 Global Dermatology Drugs Market Forecast by Generics/Biologics 2022, 2027, 2032 (Revenue, CAGR %)
Figure 45 Global Dermatology Drugs Market Share Forecast by Generics/Biologics, 2022, 2032 (%)
Figure 46 Global Dermatology Drugs Market Forecast by Generics, 2022-2032 (US$ billion, AGR %)
Figure 47 Global Dermatology Drugs Market Forecast by Biologics, 2022-2032 (US$ billion, AGR %)
Figure 48 Global Dermatology Drugs Market Forecast by Region 2022, 2027, 2032 (Revenue), C
Figure 49 Global Dermatology Drugs Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 50 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%))
Figure 51 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 52 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 53 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 54 Global Dermatology Drugs Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 55 North America Dermatology Drugs Market Attractiveness Index, 2022
Figure 56 North America Dermatology Drugs Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 57 North America Dermatology Drugs Market Forecast by Country, 2022-2032 (US$ billion, AGR %)
Figure 58 North America Dermatology Drugs Market Share Forecast by Country, 2022 & 2032 (%)
Figure 59 North America Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 60 North America Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 61 North America Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 62 North America Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 63 U.S. Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 64 U.S. Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 65 U.S. Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 66 U.S. Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 67 U.S. Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 68 Canada Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 69 Canada Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 70 Canada Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 71 Canada Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 72 Canada Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 73 Europe Dermatology Drugs Market Attractiveness Index
Figure 74 Europe Dermatology Drugs Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 75 Europe Dermatology Drugs Market Forecast by Country, 2022-2032 (US$ billion, AGR %)
Figure 76 Europe Dermatology Drugs Market Share Forecast by Country, 2022 & 2032 (%)
Figure 77 Europe Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 78 Europe Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 79 Europe Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 80 Europe Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 81 Germany Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 82 Germany Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 83 Germany Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 84 Germany Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 85 Germany Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 86 UK Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 87 U.K. Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 88 U.K. Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 89 U.K. Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 90 U.K. Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 91 France Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 92 France Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 93 France Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 94 France Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 95 France Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 96 Italy Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 97 Italy Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 98 Italy Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 99 Italy Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 100 Italy Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 101 Spain Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 102 Spain Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 103 Spain Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 104 Spain Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 105 Spain Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 106 Russia Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 107 Russia Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 108 Russia Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 109 Russia Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 110 Russia Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 111 Rest of Europe Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 112 Rest of Europe Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 113 Rest of Europe Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 114 Rest of Europe Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 115 Rest of Europe Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 116 Asia Pacific Dermatology Drugs Market Attractiveness Index
Figure 117 Asia Pacific Dermatology Drugs Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 118 Asia Pacific Dermatology Drugs Market Forecast by Country, 2022-2032 (US$ billion, AGR %)
Figure 119 Asia Pacific Dermatology Drugs Market Share Forecast by Country, 2022 & 2032 (%)
Figure 120 Asia Pacific Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 121 Asia Pacific Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 122 Asia Pacific Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 123 Asia Pacific Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 124 Japan Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 125 Japan Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 126 Japan Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 127 Japan Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 128 Japan Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 129 China Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 130 China Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 131 China Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 132 China Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 133 China Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 134 India Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 135 India Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 136 India Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 137 India Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 138 India Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 139 South Korea Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 140 South Korea Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 141 South Korea Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 142 South Korea Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 143 South Korea Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 144 Australia Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 145 Australia Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 146 Australia Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 147 Australia Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 148 Australia Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 149 Rest of Asia Pacific Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 150 Rest of APAC Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 151 Rest of APAC Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 152 Rest of APAC Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 153 Rest of APAC Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 154 Latin America Dermatology Drugs Market Attractiveness Index
Figure 155 Latin America Dermatology Drugs Market by Region, 2022, 2027 & 2032 (US$ billion)
Figure 156 Latin America Dermatology Drugs Market Forecast by Country, 2022-2032 (US$ billion, AGR %)
Figure 157 Latin America Dermatology Drugs Market Share Forecast by Country, 2022 & 2032 (%)
Figure 158 Latin America Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 159 Latin America Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 160 Latin America Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 161 Latin America Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 162 Brazil Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 163 Brazil Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR %)
Figure 164 Brazil Dermatology Drugs Market Share Forecast by Disease, 2022 & 2032 (%)
Figure 165 Brazil Dermatology Drugs Market Forecast by Route of Administration, 2022-2032 (US$ billion, AGR %)
Figure 166 Brazil Dermatology Drugs Market Share Forecast by Route of Administration, 2022 & 2032 (%)
Figure 167 Mexico Dermatology Drugs Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 168 Mexico Dermatology Drugs Market Forecast by Disease, 2022-2032 (US$ billion, AGR

List of Companies Profiled in the Report
Abbott Laboratories
AbbVie
Bayer Pharmaceuticals
BMS
Cipla Pharmaceutical
Dr. Reddy’s Laboratories
Eli Lilly and Company
Glenmark Pharmaceuticals Limited
GSK
Janssen Pharma
Lupin Limited
Merck
Pfizer
Roche
Sanofi Pasteur Pharmaceutical
Sun Pharmaceutical Industries Limited
Taro Pharmaceutical Industries Ltd.
Zydus Cadila Healthcare Pharmaceutical

List of Other Companies Mentioned in the Report
Abbott
Actavis
AET BioTech
Alkem Laboratories
Allergan
Almirall
Amgen
Anacor
Ascend Therapeutics
Astellas
Aurobindo
Barr Labs
Bayer
Betta Pharmaceuticals
Biocon/Mylan
Biofrontera
Biogen
Biovail Laboratories
BioXpress Therapeutics
Boehringer Ingelheim
Brazilian Society of Dermatology
Bristol-Myers Squibb
Cadila Healthcare
Calico
Can-Fite BioPharma
Cassiopea SpA
Celgene
Celltrion
Cempra
Cipher Pharmaceuticals
Cipla
Colorescience
Cubist Pharmaceuticals
Cutanea Life Sciences
Dow Pharmaceuticals Science
Dr Reddy’s
Durata Therapeutics
Eisai
Eli Lilly
European Medicines Agency (EMA)
European Pharmaceutical Market Research Association (EPhMRA)
FibroTx
Foamix
Food and Drug Association (FDA)
Fougera
Fujifilm
G&E Herbal Biotechnology
Galapagos NV
Galderma
GlaxoSmithKline
Glenmark Pharmaceuticals
Heritage
Impax
Incyte
International Health Partners
Janssen Biotech
Johnson & Johnson
Kyowa Hakko Kirin
L’Oreal
LEO Pharma
Lupin
Maruho
Mayne Pharma
Medicis
Medison Pharma
Melinta Pharmaceuticals
Merz Pharmaceuticals
Mitsubishi Tanabe
MorphoSys
Mylan
NanoBio Corporation
National Psoriasis Foundation (NPF)
NeoStrata Company Inc
Nestle Skin Health
Novan
Novartis
Perriogo
PharmaPraxis
Photocure
Pierre Fabre
Provectus Biopharmaceuticals
QLT Inc
Ranbaxy
Regeneron Pharmaceuticals
Samsung Bioepis
Samsung Biologics
Sandoz
Sanofi
Schering-Plough
Shanghai CP Buojian Pharmaceutical
Sidmak Labs
Sol-Gel Technologies Ltd
Sun Pharma
Sunovion
Takeda
Tanabe
Tanja Todberg
Taro Pharmaceuticals
Teva
Thesan Pharmaceuticals Inc
Topica Pharmaceuticals
UCB
Valeant
Vical
Warner Chilcott
Watson Pharmaceuticals
Xenon Pharmaceuticals
Ziarco Group Limited
Zydus

List of Associations Mentioned in the Report
Brazilian Society of Dermatology
British Association of Dermatologists
Chinese Society of Dermatology
European Medicines Agency (EMA)
European Pharmaceutical Market Research Association (EPhMRA)
Food and Drug Administration (FDA) [US]
Health Canada
National Development and Reform Commission (NDRC) [China]
National Health Services (NHS) [UK]
National Institute for Health and Care Excellence (NICE) [UK]
National Institute of Allergy and Infectious Diseases (NIAID) [US]
National Institutes of Health [US]
National Pharmaceutical Pricing Authority (NPPA) [China]
Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]
Servicio Sanitario Nazionale (SSN) [US]
St. Luke’s-Roosevelt Hospital Center, New York [US]
UK Medicines and Healthcare Products Regulatory Agency (MHRA)
United States District Court for the District of New Jersey
University of California, San Diego [US]
University of Michigan [US]
US Patent Office

$4,740.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

[email protected]
+1 212 564 2838

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

[email protected]
+1 212 564 2838

Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838